Adaptive Biotechnologies (ADPT) Return on Capital Employed Growth (3y) (2022 - 2026)
Adaptive Biotechnologies (ADPT) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -80.00 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -312.00 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 1,361.00 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -383.00 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 4,725.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 84.00 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 10,173.00 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -363.00 |
| 10 | Adaptive Biotechnologies | 2.71 Bn | 2.50 Bn | 52.17 Mn | 1,541.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,541.00 |
| Dec 31, 2025 | 1,245.00 |
| Sep 30, 2025 | 1,097.00 |
| Jun 30, 2025 | 296.00 |
| Mar 31, 2025 | -304.00 |
| Dec 31, 2024 | -1,130.00 |
| Sep 30, 2024 | -1,976.00 |
| Jun 30, 2024 | -2,398.00 |
| Mar 31, 2024 | -2,304.00 |
| Dec 31, 2023 | -2,248.00 |
| Sep 30, 2023 | -1,494.00 |
| Jun 30, 2023 | -1,303.00 |
| Mar 31, 2023 | -1,508.00 |
| Dec 31, 2022 | -1,695.00 |
| Sep 30, 2022 | -2,006.00 |